Active-ingredient Dossier
Clarithromycin
Active-ingredient Dossier for Clarithromycin (macrolide antibiotic). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: KLACID
- Brand: CLARITHRO
- Brand: CLARITHROMYCIN SANDOZ
- Brand: ESOMEPRAZOLE
- Brand: KALIXOCIN
- Brand: NEXIUM
- Therapeutic area: Infectious Disease
- Therapeutic area: Gastroenterology
What is
Clarithromycin Clarithromycin is a macrolide antibiotic.
Australian brands containing
Clarithromycin — KLACID — NEXIUM — CLARITHRO — CLARITHROMYCIN SANDOZ — KALIXOCIN — APO-CLARITHROMYCIN — CLARITHROM — CLARITHROMYCIN-WGR — MYTHRINE
Therapeutic areas
Clarithromycin is registered in infectious disease (8 brands) and gastroenterology (1 brand).
Sponsor landscape
Clarithromycin is marketed by Arrotex Pharmaceuticals, Strides Pharma Science, Viatris, Sandoz, and AstraZeneca.
PBS and regulatory activity
One brand containing clarithromycin has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2017.